Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-κB transcriptional activation and cytokine secretion

被引:293
作者
Yeh, CH
Sturgis, L
Haidacher, J
Zhang, XN
Sherwood, SJ
Bjercke, RJ
Juhasz, O
Crow, MT
Tilton, RG
Denner, L
机构
[1] Texas Biotechnol Corp, Dept Cell Biol, Houston, TX 77030 USA
[2] Texas Biotechnol Corp, Apoptosis Program, Houston, TX 77030 USA
[3] Texas Biotechnol Corp, Dept Immunol, Houston, TX 77030 USA
[4] NIA, Cardiovasc Sci Lab, NIH, Baltimore, MD USA
关键词
D O I
10.2337/diabetes.50.6.1495
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Advanced glycation end product (AGE) activation of the signal-transducing receptor for AGE (RAGE) has been linked to a proinflammatory phenotypic change within cells. However, the precise intracellular signaling pathways involved have not been elucidated. We demonstrate here that human serum albumin modified with N-epsilon-(carboxymethyl)lysine (CML), a major AGE adduct that progressively accumulates with aging, diabetes, and renal failure, induced nuclear factor (NF)-kappaB-driven reporter gene expression in human monocytic THP-1 cells. The NF-kappaB response was blocked with a synthetic peptide corresponding to the putative ligand-binding domain of RAGE, with anti-RAGE antiserum, and by coexpression of truncated receptors lacking the intracellular domain. Signal transduction from RAGE to NF-kappaB involved the generation of reactive oxygen species, since reporter gene expression was blocked with the antioxidant N-acetyl-L-cysteine. CML-modified albumin produced rapid transient activation of tyrosine phosphorylation, extracellular signal-regulated kinase 1 and 2, and p38 mitogen-activated protein kinase (MAPK), but not c-Jun NH2-terminal kinase. RAGE-mediated NF-kappaB activation was suppressed by the selective p38 MAPK inhibitor SB203580 and by coexpression of a kinase-dead p38 dominant-negative mutant. Activation of NF-kappaB by CML-modified albumin increased secretion of proinflammatory cytokines (tumor necrosis factor-alpha, interleukin-1 beta, and monocyte chemoattractant protein-1) severalfold, and inhibition of p38 MAPK blocked these increases. These results indicate that p38 MAPK activation mediates RAGE-induced NF-kappaB-dependent secretion of proinflammatory cytokines and suggest that accelerated inflammation may be a consequence of cellular activation induced by this receptor.
引用
收藏
页码:1495 / 1504
页数:10
相关论文
共 60 条
[1]   An essential role for NF-kappa B in preventing TNF-alpha-induced cell death [J].
Beg, AA ;
Baltimore, D .
SCIENCE, 1996, 274 (5288) :782-784
[2]   IκBα degradation and nuclear factor-κB DNA binding are insufficient for interleukin-1β and tumor necrosis factor-α-induced κB-dependent transcription -: Requirement for an additional activation pathway [J].
Bergmann, M ;
Hart, L ;
Lindsay, M ;
Barnes, PJ ;
Newton, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (12) :6607-6610
[3]   Molecular mechanisms of diabetic angiopathy - Clues for innovative therapeutic interventions [J].
Bierhaus, A ;
Ziegler, R ;
Nawroth, PP .
HORMONE RESEARCH, 1998, 50 :1-5
[4]  
Bierhaus A, 1997, CIRCULATION, V96, P2262
[5]  
BRETT J, 1993, AM J PATHOL, V143, P1699
[6]   ADVANCED PROTEIN GLYCOSYLATION IN DIABETES AND AGING [J].
BROWNLEE, M .
ANNUAL REVIEW OF MEDICINE, 1995, 46 :223-234
[7]  
Bucala R, 1992, Adv Pharmacol, V23, P1
[8]   p38 MAPK inhibition decreases TNF-α production and enhances postischemic human myocardial function [J].
Cain, BS ;
Meldrum, DR ;
Meng, XZ ;
Dinarello, CA ;
Shames, BD ;
Banerjee, A ;
Harken, AH .
JOURNAL OF SURGICAL RESEARCH, 1999, 83 (01) :7-12
[9]   The p38 mitogen-activated protein kinase is required for NF-κB-dependent gene expression -: The role of TATA-binding protein (TBP) [J].
Carter, AB ;
Knudtson, KL ;
Monick, MM ;
Hunninghake, GW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (43) :30858-30863
[10]   The serum concentration of the advanced glycation end-product N-epsilon-(carboxymethyl)lysine is increased in uremia [J].
Degenhardt, TP ;
Grass, L ;
Reddy, S ;
Thorpe, SR ;
Diamandis, EP ;
Baynes, JW .
KIDNEY INTERNATIONAL, 1997, 52 (04) :1064-1067